Optimizing Immunomodulatory Drug With Proteasome Inhibitor Combinations in Newly Diagnosed Multiple Myeloma
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference73 articles.
1. Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016;JAMA Oncol,2018
2. Analysis of long-term survival in multiple myeloma after first-line autologous stem cell transplantation: impact of clinical risk factors and sustained response;Cancer Med,2018
3. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients;Leukemia,2014
4. Multiple myeloma;Ann Oncol,2010
5. Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agents;Leuk Res,2010
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anti-tumor effect of dandelion flavone on multiple myeloma cells and its mechanism;Discover Oncology;2024-06-08
2. Targeted therapy for multiple myeloma: an overview on CD138-based strategies;Frontiers in Oncology;2024-04-09
3. Unmasking Infection Risks in Multiple Myeloma: Insights from a Retrospective Analysis;Indian Journal of Hematology and Blood Transfusion;2024-03-25
4. Response and Dynamics of Renal Function in Transplantation-Eligible Multiple Myeloma Patients Treated with a Novel Agent: The CAREMM-2201 Study;Transplantation and Cellular Therapy;2023-01
5. Adding recombinant AAVs to the cancer therapeutics mix;Molecular Therapy - Oncolytics;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3